{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:03:11Z","timestamp":1775977391235,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["643417"],"award-info":[{"award-number":["643417"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["21163"],"award-info":[{"award-number":["21163"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CENTRO-01-0145-FEDER-022095"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-022095"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/NMC\/0331\/2012"],"award-info":[{"award-number":["EXPL\/NMC\/0331\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016390"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016390"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016719"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016719"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016807"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016807"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-029716"],"award-info":[{"award-number":["POCI-01-0145-FEDER-029716"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/51673\/2011"],"award-info":[{"award-number":["SFRH\/BD\/51673\/2011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/61461\/2009"],"award-info":[{"award-number":["SFRH\/BD\/61461\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/66705\/2009"],"award-info":[{"award-number":["SFRH\/BPD\/66705\/2009"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jmoldx.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T20:36:14Z","timestamp":1584736574000},"page":"782-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protocol for the Characterization of the Cytosine-Adenine-Guanine Tract and Flanking Polymorphisms in Machado-Joseph Disease"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-8529","authenticated-orcid":false,"given":"Sara M.","family":"Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ros\u00e1rio","family":"Faro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-0203","authenticated-orcid":false,"given":"Miguel M.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4937-448X","authenticated-orcid":false,"given":"Isabel","family":"Onofre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8197-8451","authenticated-orcid":false,"given":"Nuno","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Janu\u00e1rio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Jorge","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-3307","authenticated-orcid":false,"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2020.03.003_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrg1691","article-title":"Diseases of unstable repeat expansion: mechanisms and common principles","volume":"6","author":"Gatchel","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrn1474","article-title":"Pathways to motor incoordination: the inherited ataxias","volume":"5","author":"Taroni","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3727\/096368914X678454","article-title":"Polyglutamine (PolyQ) diseases: genetics to treatments","volume":"23","author":"Fan","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","article-title":"Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7","volume":"104","author":"R\u00fcb","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrn.2017.92","article-title":"Polyglutamine spinocerebellar ataxias\u2014from genes to potential treatments","volume":"18","author":"Paulson","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib6","first-page":"54","article-title":"Correlation between CAG repeat length and clinical features in Machado-Joseph disease","volume":"57","author":"Maciel","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib7","first-page":"809","article-title":"Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia-3\/Machado-Joseph disease locus","volume":"57","author":"Cancel","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/hmg\/4.5.807","article-title":"Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease","volume":"4","author":"Maruyama","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","article-title":"Improvement in the molecular diagnosis of Machado-Joseph disease","volume":"58","author":"Maciel","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ejhg.2010.10","article-title":"Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias","volume":"18","author":"Sequeiros","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ejhg.2010.8","article-title":"European Molecular Quality Genetics Network: EMQN best practice guidelines for molecular genetic testing of SCAs","volume":"18","author":"Sequeiros","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s004390050552","article-title":"High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis","volume":"100","author":"Larsen","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/mcpr.1999.0248","article-title":"Comparative semi-automated analysis of (CAG) repeats in the Huntington disease gene: use of internal standards","volume":"13","author":"Williams","year":"1999","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1525-1578(10)60689-7","article-title":"Diagnosis of five spinocerebellar ataxia disorders by multiplex amplification and capillary electrophoresis","volume":"4","author":"Dorschner","year":"2002","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12031-015-0646-y","article-title":"Verification of inter-laboratorial genotyping consistency in the molecular diagnosis of polyglutamine spinocerebellar ataxias","volume":"58","author":"Ramos","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(04)00737-9","article-title":"Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis","volume":"3","author":"Sch\u00f6ls","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib17","article-title":"Trends in the epidemiology of spinocerebellar ataxia type 3\/Machado-Joseph disease in the Azores Islands, Portugal","volume":"1","author":"de Ara\u00fajo","year":"2016","journal-title":"JSM Brain Sci"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ng0793-300","article-title":"The gene for Machado-Joseph disease maps to human chromosome 14q","volume":"4","author":"Takiyama","year":"1993","journal-title":"Nat Genetics"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat Genetics"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-6-35","article-title":"Machado-Joseph disease: from first descriptions to new perspectives","volume":"6","author":"Bettencourt","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","article-title":"Glutamine repeats and neurodegeneration","volume":"23","author":"Zoghbi","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pediatrneurol.2007.12.006","article-title":"Homozygosity enhances severity in spinocerebellar ataxia type 3","volume":"38","author":"Carvalho","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ana.410360318","article-title":"Homozygous inheritance of the Machado-Joseph disease gene","volume":"36","author":"Lang","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib24","series-title":"Polyglutamine Disorders","first-page":"395","article-title":"Gene therapies for polyglutamine diseases","author":"Matos","year":"2018"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib25","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1073\/pnas.1231012100","article-title":"Allele-specific silencing of dominant disease genes","volume":"100","author":"Miller","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib26","doi-asserted-by":"crossref","first-page":"e3341","DOI":"10.1371\/journal.pone.0003341","article-title":"Allele-specific RNA silencing of mutant ataxin-3 mediates neuroprotection in a rat model of Machado-Joseph disease","volume":"3","author":"Alves","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib27","doi-asserted-by":"crossref","first-page":"e52396","DOI":"10.1371\/journal.pone.0052396","article-title":"Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice","volume":"8","author":"N\u00f3brega","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","article-title":"Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype","volume":"82","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib29","first-page":"1247","article-title":"Linkage disequilibrium at the Machado-Joseph disease\/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation","volume":"57","author":"Stevanin","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s004390050270","article-title":"Linkage disequilibrium analysis in Machado-Joseph disease patients of different ethnic origins","volume":"98","author":"Gaspar","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318184","article-title":"Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study","volume":"68","author":"Gaspar","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0168-0102(97)00056-4","article-title":"Machado-Joseph disease gene products carrying different carboxyl termini","volume":"28","author":"Goto","year":"1997","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s100380200025","article-title":"Identification of three novel polymorphisms in the MJD1 gene and study of their frequency in the Portuguese population","volume":"47","author":"Costa","year":"2002","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib34","first-page":"993","article-title":"Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients","volume":"60","author":"Maciel","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.0.CO;2-M","article-title":"Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3\/Machado-Joseph disease","volume":"11","author":"Cancel","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib36","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ejhg.2008.29","article-title":"Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias","volume":"16","author":"Seneca","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib37","first-page":"9.30.1","article-title":"Diagnosis of spinocerebellar ataxias caused by trinucleotide repeat expansions","volume":"92","author":"Martindale","year":"2017","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib38","doi-asserted-by":"crossref","first-page":"e0134405","DOI":"10.1371\/journal.pone.0134405","article-title":"Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population","volume":"10","author":"Gan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1022441101801","article-title":"Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA)","volume":"23","author":"Ito","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jmoldx.2017.12.006","article-title":"Spinocerebellar ataxia tethering PCR: a rapid genetic test for the diagnosis of spinocerebellar ataxia types 1, 2, 3, 6, and 7 by PCR and capillary electrophoresis","volume":"20","author":"Cagnoli","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/01677063.2015.1073275","article-title":"Allele-selective suppression of mutant genes in polyglutamine diseases","volume":"29","author":"Liu","year":"2015","journal-title":"J Neurogenet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.14541","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J Neurochem"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2017.11.051","article-title":"Experimental and clinical strategies for treating spinocerebellar ataxia type 3","volume":"371","author":"Wang","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib44","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archneur.64.10.1502","article-title":"Asian origin for the worldwide-spread mutational event in Machado-Joseph disease","volume":"64","author":"Martins","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib45","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/hmg\/ddq111","article-title":"Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?","volume":"19","author":"Alves","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib47","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/mt.2013.144","article-title":"Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease","volume":"21","author":"Costa Mdo","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib48","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","volume":"21","author":"Rodr\u00edguez-Lebr\u00f3n","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jmoldx.2020.03.003_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann Neurol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515782030057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515782030057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:13:44Z","timestamp":1761502424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152515782030057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S152515782030057X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2020.03.003","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for the Characterization of the Cytosine-Adenine-Guanine Tract and Flanking Polymorphisms in Machado-Joseph Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}